ARCHIVES

OMB Reprogramming Ban Criticized

This article is from The Cancer Letter archive.

Vol. 11 No. 36 | September 20, 1985

Download PDF Visit The Full Archive

Related Articles

FDA Approves Imaging Agent For Recurrent Prostate Cancer

September 28, 2012

ASCO Annual Meeting: NCI goals: Expand Clinical Trials, Build Informatics Network

May 30, 1997

Eleven Chemicals Rated for Tests

September 1, 1978

DOD Names Innovator Award Recipients.

April 26, 2002

Minimally Invasive Surgery Results In Lower Mortality Rate For Esophageal Removal

April 25, 2003

NCI Staff Discusses New Guidelines for Core Grant Reviews, Comprehensiveness

July 24, 1992